Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAlterity Therapeutics Ltd Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Alterity Therapeutics Ltd Earnings Date And Information
Alterity Therapeutics Ltd last posted its earnings results on Wednesday, February 25th, 2026. The company reported $-0.38337 earnings per share for the quarter, missing analysts' consensus estimates of $-0.23107 by $0.1523. The company had revenue of 0 for the quarter and had revenue of 5.44 M for the year. Alterity Therapeutics Ltd has generated $-1 earnings per share over the last year ($-1.14 diluted earnings per share) and currently has a price-to-earnings ratio of -6.98. Alterity Therapeutics Ltd has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Alterity Therapeutics Ltd Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 01/30/2026 | Q2 2026 | N/A | -$0.54 | N/A | $1.08 M | $0 |
| 08/28/2025 | Q4 2025 | N/A | -$0.42 | N/A | $3.83 M | $3.83 M |
| 02/28/2025 | Q2 2025 | N/A | -$0.84 | N/A | $1.50 M | $1.61 M |
| 09/26/2024 | Q4 2024 | N/A | -$1.20 | N/A | N/A | $2.12 M |
| 02/28/2024 | Q2 2024 | N/A | -$1.56 | N/A | N/A | $1.90 M |
| 06/30/2023 | Q4 2023 | N/A | -$1.44 | N/A | N/A | $1.53 M |
| 12/30/2022 | Q2 2023 | N/A | -$1.98 | N/A | N/A | $2.39 M |
| 06/29/2022 | Q4 2022 | N/A | -$1.56 | N/A | N/A | $2.76 M |
| 12/30/2021 | Q2 2022 | N/A | -$1.62 | N/A | N/A | $2.36 M |
| 06/30/2021 | Q4 2021 | N/A | -$1.92 | N/A | N/A | $2.46 M |
| 12/31/2020 | Q2 2021 | N/A | -$3.90 | N/A | N/A | $1.88 M |
| 06/30/2020 | Q4 2020 | N/A | -$5.10 | N/A | N/A | $-1,855,172 |
| 12/31/2019 | Q2 2020 | N/A | -$3.90 | N/A | N/A | $1.86 M |
| 06/30/2019 | Q4 2019 | N/A | -$6.06 | N/A | N/A | $2.52 M |
| 12/31/2018 | Q2 2019 | N/A | -$5.94 | N/A | N/A | $2.43 M |
| 06/30/2018 | Q4 2018 | N/A | -$5.22 | N/A | N/A | $1.65 M |
| 12/31/2017 | Q2 2018 | N/A | -$4.08 | N/A | N/A | $1.48 M |
| 06/30/2017 | Q4 2017 | N/A | -$4.38 | N/A | N/A | $1.25 M |
| 12/31/2016 | Q2 2017 | N/A | -$4.08 | N/A | N/A | $1.90 M |
| 06/29/2016 | Q4 2016 | N/A | -$5.52 | N/A | N/A | $2.04 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Alterity Therapeutics Ltd Earnings: FAQ's
The conference call for Alterity Therapeutics Ltd's latest earnings report can be listened to online.
The conference call transcript for Alterity Therapeutics Ltd's latest earnings report can be read online.
Alterity Therapeutics Ltd (:ATHE) has a recorded annual revenue of $5.44 M.
Alterity Therapeutics Ltd (:ATHE) has a recorded net income of $-12,147,828.Alterity Therapeutics Ltd has generated $-1.14 earnings per share over the last four quarters.
Alterity Therapeutics Ltd (:ATHE) has a price-to-earnings ratio of -6.98 and price/earnings-to-growth ratio is -0.04.